The estimated Net Worth of Jens Luehring is at least $1.59 Thousand dollars as of 9 December 2016. Jens Luehring owns over 20,000 units of Bellerophon Therapeutics Inc stock worth over $1,594 and over the last 10 years Jens sold BLPH stock worth over $0.
Jens has made over 2 trades of the Bellerophon Therapeutics Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Jens bought 20,000 units of BLPH stock worth $11,200 on 9 December 2016.
The largest trade Jens's ever made was buying 358,916 units of Bellerophon Therapeutics Inc stock on 19 February 2015 worth over $4,306,992. On average, Jens trades about 34,447 units every 60 days since 2015. As of 9 December 2016 Jens still owns at least 39,860 units of Bellerophon Therapeutics Inc stock.
You can see the complete history of Jens Luehring stock trades at the bottom of the page.
Jens's mailing address filed with the SEC is 200 Somerset Corporate Blvd, Bridgewater, NJ 08807, USA.
Over the last 10 years, insiders at Bellerophon Therapeutics Inc have traded over $8,853,497 worth of Bellerophon Therapeutics Inc stock and bought 9,412,012 units worth $57,370,250 . The most active insiders traders include Robert Nelsen, Adam Weinstein, and Associates Iv L P Venrock H.... On average, Bellerophon Therapeutics Inc executives and independent directors trade stock every 61 days with the average trade being worth of $10,679. The most recent stock trade was executed by Capital Management Lp Puiss... on 13 October 2023, trading 1,076,841 units of BLPH stock currently worth $107,684.
bellerophon therapeutics is a clinical-stage biotherapeutics company focused on developing innovative products combining novel drugs and devices in the treatment of cardiopulmonary and cardiac diseases. our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need.
Bellerophon Therapeutics Inc executives and other stock owners filed with the SEC include: